Nano-carrier mediated co-delivery of methyl prednisolone and minocycline for improved post-traumatic spinal cord injury conditions in rats

References

• Rossi F, Ferrari R, Papa S, et al. Tunable hydrogel-nanoparticles release system for sustained combination therapies in the spinal cord. Colloids Surf B Biointerfaces 2013;108:169–77.
   PubMed Web of Science ®Google Scholar
• Ren H, Han M, Zhou J, et al. Repair of spinal cord injury by inhibition of astrocyte growth and inflammatory factor synthesis through local delivery of flavopiridol in PLGA nanoparticles. Biomaterials 2014;35:6585–94.
   PubMed Web of Science ®Google Scholar
• Kim YT, Caldwell JM, Bellamkonda RV. Nanoparticle-mediated local delivery of methylprednisolone after spinal cord injury. Biomaterials 2009;30:2582–90.
   PubMed Web of Science ®Google Scholar
• Paterniti I, Impellizzeri D, Di Paola R, et al. A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury. J Neuroinflamm 2013;10:91.
   PubMed Web of Science ®Google Scholar
• Gwak SJ, Koo H, Yun Y, et al. Multifunctional nanoparticles for gene delivery and spinal cord injury. J Biomed Mater Res Part A 2015;103:3474–82.
   PubMed Web of Science ®Google Scholar
• Stirling DP, Khodarahmi K, Liu J, et al. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci 2004;24:2182–90.
   PubMed Web of Science ®Google Scholar
• Shah PP, Desai PR, Patel AR, Singh MS. Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs. Biomaterials 2012;33:1607–17.
   PubMed Web of Science ®Google Scholar
• Saivin S, Houin G. Clinical pharmacokinetics of doxycycline and minocycline. Clin Pharmacokinet 1988;15:355–66.
   PubMed Web of Science ®Google Scholar
• Al-Habet SM, Rogers HJ. Methylprednisolone pharmacokinetics after intravenous and oral administration. Br J Clin Pharmacol 1989;27:285–90.
   PubMed Web of Science ®Google Scholar
• Zhang S, Ermann J, Succi MD, et al. An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease. Sci Transl Med 2015;7:300ra128.
   PubMed Web of Science ®Google Scholar
• Kandadi P, Syed MA, Goparaboina S, Veerabrahma K. Albumin coupled lipid nanoemulsions of diclofenac for targeted delivery to inflammation. Nanomedicine: Nanotechnol Biol Med 2012;8:1162–71.
   PubMed Web of Science ®Google Scholar
• Chronopoulou L, Massimi M, Giardi MF, et al. Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures. Colloids Surf B Biointerfaces 2013;103:310–7.
   PubMed Web of Science ®Google Scholar
• Lü J-M, Wang X, Marin-Muller C, et al. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn 2009;9:325–41.
   PubMed Web of Science ®Google Scholar
• Manoochehri S, Darvishi B, Kamalinia G, et al. Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel. DARU J Pharm Sci 2013;21:58.
   Web of Science ®Google Scholar
• Tiruppathi C, Song W, Bergenfeldt M, et al. Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J Biol Chem 1997;272:25968–75.
   PubMed Web of Science ®Google Scholar
• Merlot AM, Kalinowski DS, Richardson DR. Unraveling the mysteries of serum albumin-more than just a serum protein. Front Physiol 2014;5:299.
   PubMed Web of Science ®Google Scholar
• Marin MT, Margarit MV, Salcedo GE. Characterization and solubility study of solid dispersions of flunarizine and polyvinylpyrrolidone. Farmaco (Societa Chimica Italiana: 1989) 2002;57:723–7.
   PubMedGoogle Scholar
• Navarro SM, Darensbourg C, Cross L, et al. Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days. Ther Deliv 2014;5:1191–201.
   PubMedGoogle Scholar
• Solomon B, Sahle FF, Gebre-Mariam T, et al. Microencapsulation of citronella oil for mosquito-repellent application: formulation and in vitro permeation studies. Eur J Pharm Biopharm 2012;80:61–6.
   PubMed Web of Science ®Google Scholar
• Jing X, Deng L, Gao B, et al. A novel polyethylene glycol mediated lipid nanoemulsion as drug delivery carrier for paclitaxel. Nanomedicine: Nanotechnol Biol Med 2014;10:371–80.
   PubMed Web of Science ®Google Scholar
• Shafiq S, Shakeel F, Talegaonkar S, et al. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 2007;66:227–43.
   PubMed Web of Science ®Google Scholar
• Rai VK, Yadav NP, Sinha P, et al. Development of cellulosic polymer based gel of novel ternary mixture of miconazole nitrate for buccal delivery. Carbohydr Polym 2014;103:126–33.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Chen X, Liu Z, et al. Interleukin-10 protection against lipopolysaccharide-induced neuro-inflammation and neurotoxicity in ventral mesencephalic cultures. Int J Mol Sci 2015;17:25.
   Web of Science ®Google Scholar
• Song Y, Xue H, Liu TT, et al. Rapamycin plays a neuroprotective effect after spinal cord injury via anti-inflammatory effects. J Biochem Mol Toxicol 2015;29:29–34.
   PubMed Web of Science ®Google Scholar
• Wang YT, Lu XM, Zhu F, et al. The use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured rats. Biomaterials 2011;32:7988–98.
   PubMed Web of Science ®Google Scholar
• Xue M, Mikliaeva EI, Casha S, et al. Improving outcomes of neuroprotection by minocycline: guides from cell culture and intracerebral hemorrhage in mice. Am J Pathol 2010;176:1193–202.
   PubMed Web of Science ®Google Scholar
• Festoff BW, Ameenuddin S, Arnold PM, et al. Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury. J Neurochem 2006;97:1314–26.
   PubMed Web of Science ®Google Scholar
• Mishra N, Rai VK, Yadav KS, et al. Encapsulation of mentha oil in chitosan polymer matrix alleviates skin irritation. AAPS PharmSciTech 2016;17:482–92.
   PubMed Web of Science ®Google Scholar
• Michel MCP, Guimarães AG, Paula CA, et al. Extracts from the leaves of Campomanesia velutina inhibits production of LPS/INF-³ induced inflammatory mediators in J774A.1 cells and exerts anti-inflammatory and antinociceptive effects in vivo. Rev Brasil Farmacog 2013;23:927–36.
   Google Scholar
• Thompson CD, Zurko JC, Hanna BF, et al. The therapeutic role of interleukin-10 after spinal cord injury. J Neurotrauma 2013;30:1311–24.
   PubMed Web of Science ®Google Scholar
• Hejcl A, Urdzikova L, Sedy J, et al. Acute and delayed implantation of positively charged 2-hydroxyethyl methacrylate scaffolds in spinal cord injury in the rat. J Neurosurg Spine 2008;8:67–73.
   PubMed Web of Science ®Google Scholar